Morepen Laboratories Ltd.

₹42.42

- 1.03 (-2.37%)

04:01 pm - close price

BSE: MOREPENLAB

NSE: MOREPENLAB

Industry: Pharmaceuticals & Drugs

House: Morepen

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 2.15Good: 5

🟡

Adjusted EPS

Bad: 3Current: 2.15Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 15.48Good: 20

🟡

Current Ratio

Bad: 1Current: 2.32Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.78Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.46Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 2.15Good: 5

🟡

Adjusted EPS

Bad: 3Current: 2.15Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 15.48Good: 20

🟡

Current Ratio

Bad: 1Current: 2.32Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.78Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.46Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	401.04	421.77	444.55	423.07	455.22
Expenditure+	374.95	388.18	393.99	374.69	403.60
Other Income+	2.42	3.24	4.07	4.24	3.43
Operating Profit	26.09	33.59	50.57	48.38	51.62
Interest	0.28	0.46	2.17	0.80	1.15
Depreciation and Amortization	7.71	7.69	8.45	9.62	5.73
Profit Before Tax	20.51	28.68	44.02	41.74	48.17
Tax+	5.88	7.43	12.03	13.46	12.00
Net Profit	14.63	21.26	31.99	28.28	36.17

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	118805.64	154682.69	141753.00	169043.25	181157.58
Operational Expenses+	106954.23	141015.45	133799.69	153180.79	163750.55
Operating Profit	11851.41	13667.24	7953.31	15862.46	17407.03
Other Income	1206.89	2009.88	613.34	1397.08	1836.37
OPM %	9.98	8.84	5.61	9.38	9.61
Depreciation and Amortisation	3028.33	2764.25	2793.04	3346.95	2898.17
Interest	178.82	242.61	198.08	371.02	834.29
Profit Before Tax	9851.15	12670.26	5575.53	13541.57	15510.94
Tax	143.41	2776.75	1702.12	3888.57	3709.40
Net Profit	9708.59	10168.27	3867.52	9615.99	11802.04

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	85814.60	107005.27	111049.51	129320.51	177809.93
Liabilities+	85814.60	107005.27	111049.51	129320.51	177809.93

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	5082.57	-6024.02	-9117.06	7337.46	3205.67
Cash from Investing Activity	-7035.07	-3167.85	-4650.93	-8330.02	-32150.66
Cash from Financing Activity	4727.28	6633.44	14354.31	520.49	29988.60
Net Cash Flow	2774.78	-2558.43	586.32	-472.07	1043.61
Opening Cash & Cash Equivalents	1363.91	4138.69	1580.26	2166.58	1694.51
Closing Cash & Cash Equivalents	4138.69	1580.26	2166.58	1694.51	2738.12

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	35.65	35.65	35.65	35.65	35.65	38.22	38.22	38.22	38.22	38.22
Public+	64.35	64.35	64.35	64.35	64.35	61.78	61.78	61.78	61.78	61.78
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	461853	461180	468860	448361	430929	348766	336019	304289	304001	301832

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	85814.60	107005.27	111049.51	129320.51	177809.93
Liabilities+	85814.60	107005.27	111049.51	129320.51	177809.93

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	118805.64	154682.69	141753.00	169043.25	181157.58
Operational Expenses+	106954.23	141015.45	133799.69	153180.79	163750.55
Operating Profit	11851.41	13667.24	7953.31	15862.46	17407.03
Other Income	1206.89	2009.88	613.34	1397.08	1836.37
OPM %	9.98	8.84	5.61	9.38	9.61
Depreciation and Amortisation	3028.33	2764.25	2793.04	3346.95	2898.17
Interest	178.82	242.61	198.08	371.02	834.29
Profit Before Tax	9851.15	12670.26	5575.53	13541.57	15510.94
Tax	143.41	2776.75	1702.12	3888.57	3709.40
Net Profit	9708.59	10168.27	3867.52	9615.99	11802.04

Ratios

Reported EPS

Bad: 2Current: 2.15Good: 5

🟡

Adjusted EPS

Bad: 3Current: 2.15Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 15.48Good: 20

🟡

Current Ratio

Bad: 1Current: 2.32Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.78Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.46Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 2.15Good: 5

🟡

Adjusted EPS

Bad: 3Current: 2.15Good: 6

❌

Return On Capital Employed (ROCE)

Bad: 10Current: 15.48Good: 20

🟡

Current Ratio

Bad: 1Current: 2.32Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 11.78Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 4.46Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	401.04	421.77	444.55	423.07	455.22
Expenditure+	374.95	388.18	393.99	374.69	403.60
Other Income+	2.42	3.24	4.07	4.24	3.43
Operating Profit	26.09	33.59	50.57	48.38	51.62
Interest	0.28	0.46	2.17	0.80	1.15
Depreciation and Amortization	7.71	7.69	8.45	9.62	5.73
Profit Before Tax	20.51	28.68	44.02	41.74	48.17
Tax+	5.88	7.43	12.03	13.46	12.00
Net Profit	14.63	21.26	31.99	28.28	36.17

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	5082.57	-6024.02	-9117.06	7337.46	3205.67
Cash from Investing Activity	-7035.07	-3167.85	-4650.93	-8330.02	-32150.66
Cash from Financing Activity	4727.28	6633.44	14354.31	520.49	29988.60
Net Cash Flow	2774.78	-2558.43	586.32	-472.07	1043.61
Opening Cash & Cash Equivalents	1363.91	4138.69	1580.26	2166.58	1694.51
Closing Cash & Cash Equivalents	4138.69	1580.26	2166.58	1694.51	2738.12

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23	JUN'23
Promoters+	35.65	35.65	35.65	35.65	35.65	38.22	38.22	38.22	38.22	38.22
Public+	64.35	64.35	64.35	64.35	64.35	61.78	61.78	61.78	61.78	61.78
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	461853	461180	468860	448361	430929	348766	336019	304289	304001	301832

Morepen Laboratories Ltd.

₹42.42

- 1.03 (-2.37%)

04:01 pm - close price

BSE: MOREPENLAB

NSE: MOREPENLAB

Industry: Pharmaceuticals & Drugs

House: Morepen

Overview